Fill Out Your Profile to share more about you. Learn more...

Genentech Withdraws Breast Cancer Indication From Tecentriq

Options
moderators
moderators Posts: 7,928

Genentech Withdraws Breast Cancer Indication From Tecentriq
August 28, 2021

On Aug. 27, 2021, Genentech announced it is voluntarily withdrawing the breast cancer indication from the immunotherapy medicine Tecentriq in the United States. Read more...